Our observation that CEBPB expression is increased in AD-MSCs lacking SREBF1c expression may suggests that CEBPB may respond to the loss of SREBF1c to maintain the adipogenic process, possibly helping to stabilize adipocyte development in the absence of this key isoform. Here, CEBPB is linked to Alzheimer disease.